PB-301 (Panolos Bioscience)

N/A

Report date: 2023/10/09 14:19:35

Base Information

Drug NamePB-301 (Panolos Bioscience)

Drug Alias NamePB301PB-301

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody

Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitorsVascular endothelial growth factor inhibitorsTransforming growth factor beta inhibitors

TargetsEpidermal growth factor receptor erbB1Vascular endothelial growth factorTransforming growth factor beta

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesPanolos Bioscience Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A